Amid a roller-coaster end to 2024 for the stock market, dividend-paying stocks continued to lag the broader market. However, ...

'I stayed in touch with my parents, but always changed the topic when something regarding my sister came up.' She went to the "bank of Mom and Dad" often, especially after Dad passed. It annoyed my ...

Gubra A/S was the biggest leader among large stocks during the session, adding 9.7%, and Golden Ocean Group Ltd. increased 5.7%. Lundin Gold Inc. rounded out the top three leaders on Thursday, with ...

According to Bloomberg's website, an annual subscription normally costs GBP235 but at the moment is available for GBP115. Jones may have believed the story was only available on the company's terminal ...

Medical debt ought to be a different case because credit-score blemishes connected to health scares and unforeseen medical mishaps aren't a good gauge of a person's ability to repay other loans, CFPB ...

UBS's stock reached a new 16-year high on Thursday after the Wall Street Journal said the bank is about to get fined hundreds of millions of dollars.

Despite restructuring efforts, improvement in profits of the superstore business has yet to yield results. Management has taken further measures, including priority to foodservice growth with a focus ...

Investors expect the BOE to lower its key interest rate at a meeting of policy makers in early February, with further cuts to follow. The central bank lowered its key rate twice in 2024, moving at a ...

Industry officials warn of widespread economic damage on par with some of the biggest fire disasters in recent memory. Fed's Collins says her concerns about labor-market fragility have decreased The U ...

The potential payout relates to an earlier deal over tax evasion by U.S. clients of Credit Suisse, the rival Swiss bank that UBS acquired in 2023. Seven & i reported a drop in quarterly net profit but ...

Oil futures edged higher on Thursday, with U.S. and global benchmark prices turning higher for the week after posting losses day earlier, when weekly gains in U.S. product inventories outweighed ...

Medicare drug plans can now cover Eli Lilly & Co.'s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that's expected to prove a big boost for the drug company.